EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Activity

151 hedge funds and large institutions have $508M invested in EyePoint Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
-12
Holders Change %
-7.36%
% of All Funds
2.2%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.04%
New
25
Increased
64
Reduced
45
Closed
36
Calls
$6.89M
Puts
$12.1M
Net Calls
-$5.26M
Net Calls Change
+$2.91M

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$72.4M
2
SCM
2
Suvretta Capital Management
New York
$45M
3
BlackRock
3
BlackRock
New York
$32.8M
4
TCM
4
TCG Crossover Management
California
$8.02M
5
Morgan Stanley
5
Morgan Stanley
New York
$19.6M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
Millennium Management
2
Millennium Management
New York
$5.05M
3
FTM
3
First Turn Management
California
$0
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$31.2M
5
WP
5
Woodline Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TFA
176
Toth Financial Advisory
Virginia
– -$103K -5,000 Closed
Lazard Asset Management
177
Lazard Asset Management
New York
– -$81K -3,930 Closed
MLICM
178
Metropolitan Life Insurance Company (MetLife)
New York
– -$40.8K -1,974 Closed
KBC Group
179
KBC Group
Belgium
– -$23K -1,127 Closed
IC
180
Ikarian Capital
Texas
– -$21.6K -1,047 Closed
AWM
181
Avior Wealth Management
Nebraska
– -$6.53K -316 Closed
TC
182
Truvestments Capital
Florida
– -$5.33K -258 Closed
GWM
183
Geneos Wealth Management
Colorado
– -$2.4K -116 Closed
BAM
184
Bellevue Asset Management
Washington
– -$2.07K -100 Closed
PNC Financial Services Group
185
PNC Financial Services Group
Pennsylvania
– -$579 -28 Closed
4 5 6 7
8